Skip to main content
. 2012 Jan 20;22(Suppl 4):647–652. doi: 10.1007/s00586-012-2154-x

Table 3.

Resistance to second-line drugs

Drug Number of patients (out of 111) MDR (out of 90) Non MDR (out of 21)
Kanamycin 5 (4.5%) 5 (5.55%) 0
Ethionamide 39 (35.1%) 31 (34.4%) 8
PAS 8 (7.2%) 8 (8.8%) 0
Ofloxacin 36 (32.4%) 35 (38.8%) 1
Moxifloxacin 14 (12.6%) 14 (15.5%) 0
Amikacin 5 (4.5%) 5 (5.5%) 0
Capreomycin 1 (0.9%) 1 (1.1%) 0
Clofazamine 0 0 0